MedTrace Logo

Comparison of Conservative and Endovascular Treatment for Spontaneously Isolated Superior Mesenteric Artery Dissection

NCT05342233 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-04-22

No results posted yet for this study

Summary

Spontaneous isolated superior mesenteric artery dissection(SISMAD) is an increasingly diagnosed disease. However, prospective, multicenter studies that can provide evidence to support clinical decisions are very limited. This study aims to compare the therapeutic efficacy of conservative and endovascular treatment for SISMAD.

Conditions

  • Spontaneous Isolated Superior Mesenteric Artery Dissection

Sponsors & Collaborators

  • The First Medical Center of Chinese PLA General Hospital

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Renmin Hospital of Wuhan University

    collaborator OTHER

  • Peking University Shenzhen Hospital

    collaborator OTHER

  • Affiliated Hospital of Chengde Medical University

    collaborator OTHER

  • Second Affiliated Hospital of Nanchang University

    collaborator OTHER

  • Henan Provincial People's Hospital

    collaborator OTHER

  • The Affiliated Hospital of Inner Mongolia Medical University

    collaborator OTHER

  • Xiangya Hospital of Central South University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-30
Primary Completion
2027-04-01
Completion
2028-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05342233 on ClinicalTrials.gov